BEIJING, Jan. 16, 2025 /PRNewswire/ — In Ningbo, Zhejiang, David W. Ferguson, honorary chief English editor at Foreign Languages Press, met Jin Lishen, the local Fruit and Vegetable King, and included Jin’s story in his new book China’s Development in the New Era – the Zhejiang Experience.

jwplayer.key=”3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=”   jwplayer(‘myplayer1’).setup({file: ‘https://mma.prnasia.com/media2/2599566/image.mp4’, image: ‘https://mma.prnasia.com/media2/2599566/image.mp4?p=medium’, autostart:’false’, stretching : ‘uniform’, width: ‘512’, height: ‘288’});

In 1971, Jin was born in the small town of Andong, with a family whose local farming ancestry went back generations. After middle school, Jin first became a seafood fisherman, gathering cockles in Hangzhou Bay. At that time, he may not have imagined that he would become Fruit and Vegetable King of this place.

The villagers had grown cottons, soy beans, and peppers, but they still struggled to sell their produce. Jin wanted to go out and find opportunities. He used to travel extensively within Zhejiang to promote Andong’s agricultural produce.

He steadily began to build a reputation as a middle man, but logistics were still problematic.

Critical to changing the situation was the opening of the Hangzhou Bay Bridge in 2008. The bridge reduced the farmers’ travel time to Shanghai from 10 hours to two hours, and transformed their potential markets. Jin’s farms, as the tiger with wings, now reach overseas markets in Japan, Germany, the United States, Australia and Canada.

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Comviva and AWS collaborate to offer next-generation SaaS products

AWS will support Comviva in building a cloud-first, AI-driven business strategy to achieve…

Lunit Completes Acquisition of Volpara: Pioneering Next-Level of AI-Driven Cancer Care

SEOUL, South Korea, May 22, 2024 /PRNewswire/ — Lunit (KRX:328130.KQ), a leading…

MicuRx Pharmaceutical: Contezolid Global Phase III Clinical Trial Safety and Efficacy Evaluation Endorsed by Data Monitoring Committee, Promising Prospects for Diabetic Foot Infection Treatment

Data Monitoring Committee (DMC) has completed the first safety and efficacy assessment…